KRAS and colorectal carcinoma: Here we present data describing a novel antitumoral mechanism of vitamin C that involves straight inhibition of constitutively activated EGFR/MAPK pathway in KRAS mutant CRC, which in turn provokes the stalling of the Warburg metabolism.